This test is most useful if any of these apply to you.
If you have ever had a serious reaction to a wasp sting and want to better understand which insect was responsible, this test can contribute one piece of the puzzle. It looks for a specific antibody your body makes against one of the main protein triggers in paper wasp venom, called Pol d 5 (paper wasp antigen 5).
Standard venom tests use whole venom mixtures that often light up positive for both bee and wasp, leaving you and your allergist unsure which insect to actually worry about. A targeted IgE test against Pol d 5, used alongside clinical history and other venom components, can help clarify that picture and is also used to track immunologic shifts during venom immunotherapy.
Pol d 5 is the antigen 5 protein from the paper wasp Polistes dominula. It is one of the major proteins in paper wasp venom that the human immune system can react to. The test measures IgE (immunoglobulin E), an antibody type your immune system produces when it has been sensitized to a specific allergen.
Your B cells and plasma cells (specialized immune cells that produce antibodies) make these IgE antibodies after exposure to wasp venom. Detectable IgE against Pol d 5 means your immune system has learned to recognize paper wasp venom as a threat. It does not, on its own, tell you how severe a future sting reaction will be.
One useful job this test performs is helping pinpoint which stinging insect is contributing to your allergy. Whole venom extract tests frequently show positive results for multiple insects at once, because many wasps and bees share similar sugar groups on their proteins that fool the test.
In a study of Korean venom-allergic patients, the IgE test against recombinant Pol d 5 had a positive predictive value of 87.5% for paper wasp allergy in that cohort. However, an important caveat applies: antigen 5 proteins show extensive cross-reactivity across the vespid family (paper wasps, yellow jackets, hornets), and recent research has concluded that antigens 5 used alone are not reliable for distinguishing between vespid species. One study found that the ratio of yellow jacket Ves v 5 to Pol d 5 had low diagnostic accuracy (AUC of about 0.50) for separating Vespula from Polistes sensitization. In Spanish vespid-allergic patients, using antigen 5 markers (Pol d 5 and Ves v 5) along with phospholipases let researchers identify the most likely culprit species in 69% of cases, which is why current practice uses Pol d 5 as part of a multi-component panel alongside clinical history, not as a standalone discriminator.
Some people have clear systemic reactions to stings but test negative on conventional whole-venom IgE assays. Adding Pol d 5 can improve detection. In a Japanese study of patients with suspected hornet or paper wasp allergy, spiking standard venom ImmunoCAP tests with recombinant Pol d 5 and Ves v 5 raised overall sensitivity in that cohort from 80.5% to 92.7%. Five out of eight patients who initially tested negative were correctly identified as sensitized when Pol d 5 was added to the test.
All 20 non-stung control volunteers in that same study remained negative, suggesting the added sensitivity did not come at the cost of false positives in that group. These figures come from a single Japanese cohort and should not be taken as a universal miss rate.
Here is the counterintuitive part: a higher Pol d 5 IgE result does not reliably predict a more severe sting reaction. One study did find that wasp-allergic patients with the most severe reactions (Mueller grade III-IV) had higher IgE to both whole wasp venom and recombinant Pol d 5 than those with milder reactions. But across the broader literature, this relationship is inconsistent.
Studies of 194 patients with insect venom allergy and 87 bee and wasp-allergic patients found that neither skin tests nor serum IgE levels (including component IgE) reliably predicted the grade of anaphylaxis. People with low Pol d 5 IgE can still suffer severe reactions, and people with high levels sometimes have only mild ones. Think of a positive result as evidence that your immune system is primed, not as a yardstick for how dangerous your next sting will be.
It seems strange that an antibody test could help identify the allergy yet not predict how bad a reaction will be. The resolution: IgE is a sensitization marker, not a severity gauge. Reaction severity depends on additional factors like baseline tryptase levels, presence of mast cell disorders, age, and how rapidly venom enters the bloodstream. Pol d 5 IgE helps answer the question "is your immune system primed against paper wasp venom?" It does not, by itself, answer "how severe will your next sting be?"
If you are receiving venom immunotherapy (the standard disease-modifying treatment for confirmed venom allergy), Pol d 5 IgE is one of several markers that can be tracked over time. Over three years of immunotherapy in Korean vespid-allergic patients, IgE to Vespidae components including Pol d 5 declined significantly. However, across the broader literature IgE changes during immunotherapy are variable, and the rise in specific IgG4 is generally considered a more consistent marker of immunologic change. A Cochrane review also notes that levels of allergen-specific serum immunoglobulin correlate poorly with risk of reacting to a sting, meaning IgE decline during immunotherapy is an imperfect surrogate for clinical protection.
A larger Italian cohort of 491 patients similarly found that vespid markers Ves v 5 and Pol d 5 were central to species-specific sensitization and showed reductions during venom immunotherapy.
A single Pol d 5 IgE result is most useful at the start, to help confirm or rule out paper wasp sensitization after a sting reaction. If you are not on immunotherapy and your situation is stable, periodic repeat testing can establish a baseline, though clinical history usually drives decisions more than absolute IgE numbers. No specific guideline mandates a fixed retesting interval for component-specific IgE.
If you are undergoing venom immunotherapy, follow-up testing at intervals chosen by your allergist can help document immunologic changes, though current practice parameters focus on skin tests and whole-venom IgE for follow-up rather than component-specific monitoring. A trend across multiple draws is generally more informative than any single reading. Get a fresh baseline if you have a new sting reaction, regardless of past results.
Several factors can distort interpretation of any single Pol d 5 IgE reading. Understanding them prevents you from drawing the wrong conclusion.
If your Pol d 5 IgE is positive but you have never had a serious sting reaction, this usually does not require treatment. Discuss with an allergist whether to carry an epinephrine auto-injector, especially if you have high outdoor exposure. The clinical history of an actual sting reaction matters far more than the lab number alone.
If your Pol d 5 IgE is positive and you have had a systemic reaction (hives spreading beyond the sting site, throat swelling, breathing difficulty, drop in blood pressure), you are a potential candidate for venom immunotherapy and should be referred to an allergist who specializes in venom allergy. Companion tests often ordered alongside Pol d 5 include whole paper wasp venom IgE, Ves v 5 (yellow jacket antigen 5), other vespid components, CCD markers, baseline serum tryptase, and sometimes a basophil activation test for ambiguous cases. The combination, not any single number, drives the decision.
If your Pol d 5 IgE is negative but you had a clear reaction to a sting you suspect came from a paper wasp, do not assume you are in the clear. Standard venom IgE tests can miss real allergy in a meaningful minority of cases, and even component tests are imperfect. Push for a full component panel and consider a basophil activation test through an allergist.
Evidence-backed interventions that affect your Paper Wasp Venom (Pol d 5) IgE level
Paper Wasp Venom (Pol d 5) IgE is best interpreted alongside these tests.
Paper Wasp Venom (Pol d 5) IgE is included in these pre-built panels.